Bio-TechneTECHEarnings & Financial Report
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
TECH Q2 2026 Key Financial Metrics
売上高
$295.9M
粗利益
$191.3M
営業利益
$54.5M
純利益
$38.0M
粗利益率
64.6%
営業利益率
18.4%
純利益率
12.8%
前年比成長
-6.4%
EPS
$0.24
資金フロー
Bio-Techne Q2 2026 Financial Summary
Bio-Techne reported revenue of $295.9M for Q2 2026, with a net profit of $38.0M (12.8% margin). Cost of goods sold was $104.6M, operating expenses totaled $136.8M.
Key Financial Metrics
| Total Revenue | $295.9M |
|---|---|
| Net Profit | $38.0M |
| Gross Margin | 64.6% |
| Operating Margin | 18.4% |
| Report Period | Q2 2026 |
Bio-Techne Annual Revenue by Year
Bio-Techne annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.2B |
| 2024 | $1.2B |
| 2023 | $1.1B |
| 2022 | $1.1B |
損益計算書
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $303.4M | $289.5M | $297.0M | $316.2M | $316.2M | $286.6M | $295.9M | $295.9M |
| 前年比成長 | 3.2% | 4.5% | 9.0% | 4.2% | 4.2% | -1.0% | -0.4% | -6.4% |
貸借対照表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $2.70B | $2.74B | $2.67B | $2.64B | $2.56B | $2.53B | $2.52B | $2.52B |
| 総負債 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 株主資本 | $2.07B | $2.14B | $2.08B | $2.02B | $1.92B | $1.97B | $2.01B | $2.01B |
キャッシュフロー
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| 営業CF | $75.5M | $63.9M | $84.3M | $41.1M | $98.2M | $27.6M | $82.4M |
Other Health Care Companies
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
CRL
Charles River Laboratories
売上高
$994.2M
純利益
$-276.6M
DHR
Danaher Corporation
売上高
$6.1B
純利益
$908.0M
IQV
IQVIA
売上高
$4.4B
純利益
$514.0M
MTD
Mettler Toledo
売上高
$1.1B
純利益
$285.8M
TMO
Thermo Fisher Scientific
売上高
$11.1B
純利益
$1.6B
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B